FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
Notified -
Globe Newswire21-11-2024, 18:00
Nogin Announces Jonathan Huberman as Chairman and Chief 28-01-2023, 05:22